A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)
A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)
To test the safety, effectiveness of MK0217 when taken once a week for six months in treating
 patients with Paget's bone disease.
Inclusion Criteria:

 -  Male or female, ages 18 to 90 years with a diagnosis of Paget's bone disease

 Exclusion Criteria:

 -  Patient cannot stand or sit upright for at least 30 minutes

 -  Patient has difficulty swallowing or problems with digestive system